MedDataX Logo

Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis

NCT ID: NCT06173882

Last Updated: 2023-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-01

Study Completion Date

2025-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this randomized controlled clinical trial is to compare the therapeutic effect of moxibustion on allergic rhinitis. The main questions it aims to answer are:

Based on randomized controlled trials, verify the effectiveness of moxibustion in treating allergic rhinitis Based on a real-time monitoring system for human surface temperature, discuss the differences in therapeutic effects of different moxibustion doses on allergic rhinitis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Allergic rhinitis has a high incidence and is difficult to cure, seriously affecting the quality of life of patients Compare the effects of different moxibustion durations on the clinical efficacy and body surface temperature of patients with allergic rhinitis, and preliminarily explore the impact of different moxibustion doses on the efficacy of heavy moxibustion treatment for allergic rhinitis, providing evidence-based basis for clinical practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Allergic Rhinitis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

allergic rhinitis moxibustion body surface temperature

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ordinary moxibustion volume group

Group Type PLACEBO_COMPARATOR

Ordinary moxibustion volume group

Intervention Type BEHAVIORAL

Moxibustion for 10 minutes per acupoint

First group of heavy moxibustion

Group Type EXPERIMENTAL

First group of heavy moxibustion

Intervention Type BEHAVIORAL

Moxibustion for 20 minutes per acupoint

Second groups of heavy moxibustion

Group Type EXPERIMENTAL

Second groups of heavy moxibustion

Intervention Type BEHAVIORAL

Moxibustion for 30 minutes per acupoint

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ordinary moxibustion volume group

Moxibustion for 10 minutes per acupoint

Intervention Type BEHAVIORAL

First group of heavy moxibustion

Moxibustion for 20 minutes per acupoint

Intervention Type BEHAVIORAL

Second groups of heavy moxibustion

Moxibustion for 30 minutes per acupoint

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those who meet the diagnostic criteria of Chinese and Western medicine for AR;
* Age range from 18 to 75 years old, regardless of gender;
* Patients and their families are informed and agree to the study.

Exclusion Criteria

* Those who are undergoing other traditional Chinese medicine external treatment methods;
* Those who have taken traditional Chinese medicine recently or during treatment;
* Individuals who are allergic to heavy moxibustion smoke and dust;
* Individuals with concomitant bronchial asthma or other respiratory system diseases;
* Patients with severe skin diseases or ulcers in the local area where moxibustion is applied;
* Pregnant and lactating patients;
* Patients with severe diseases of important organs such as the heart, liver, lungs, and kidneys;
* Those who are unable to receive treatment according to regulations due to inconvenience in work, study, transportation, or personal activities
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Henan University of Traditional Chinese Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yang Xie, MD

Role: STUDY_DIRECTOR

Henan University of Traditonal Chinese Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The First Affiliated Hospital of Henan University of Chinese Medicine

Zhengzhou, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yang Xie, MD

Role: CONTACT

Phone: 0371-66248624

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yang Xie, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TCM for AR

Identifier Type: -

Identifier Source: org_study_id